606101-78-4 Usage
Fluoro group
A fluorine atom attached to a carbon atom in the 3-position of the tetradecahydro ring system.
Carboxylic acid group
A carboxyl (-COOH) functional group present at the 7-position of the 1H-Indeno[5,4-f]quinoline core.
Methyl ester group
A methyl (-CH3) group esterified with the carboxylic acid group.
Tetradecahydro ring system
A 14-carbon saturated hydrocarbon ring system that includes the 1H-Indeno[5,4-f]quinoline core and additional a, b, and c rings.
TriMethyl group
Three methyl (-CH3) groups attached to the tetradecahydro ring system, located at the 1, 4a, and 6a positions.
2-oxo
An oxo (=O) group present at the 2-position of the tetradecahydro ring system.
Stereochemistry
The compound has multiple stereocenters with specific configurations, including (4aS,4bS,6aS,7S,9aS,9bS,11aR).
1H-Indeno[5,4-f]quinoline derivative
It is a derivative of the 1H-Indeno[5,4-f]quinoline core, with modifications in the structure and functional groups.
Potential pharmacological implications
The unique structure and functional groups of the compound may lead to interesting biological activities and potential therapeutic applications.
Check Digit Verification of cas no
The CAS Registry Mumber 606101-78-4 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 6,0,6,1,0 and 1 respectively; the second part has 2 digits, 7 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 606101-78:
(8*6)+(7*0)+(6*6)+(5*1)+(4*0)+(3*1)+(2*7)+(1*8)=114
114 % 10 = 4
So 606101-78-4 is a valid CAS Registry Number.
606101-78-4Relevant articles and documents
Process for making fluorinated 4-azasteroid derivatives
-
Page/Page column 11-12, (2010/11/24)
The present invention relates to synthetic processes useful in the preparation of fluorinated 4-azasteroid derivatives that modulate androgen receptors and have application in the treatment of conditions caused by androgen deficiency or androgen receptor hyperactivity, such as osteoporosis, periodontal disease, bone fracture, frailty, erectile dysfunction, loss of libido, androgen-dependent cancers and sarcopenia. The present invention also encompasses intermediates useful in the disclosed synthetic processes and the methods of their preparation.
